Skip to main content
  • Entresto Out-of-Pocket Costs Out of Control?

    Study highlights one reason for "sluggish" uptake

    Lack of insurance coverage is not the issue with sacubitril/valsartan (Entresto) for many older people in the U.S. -- it's the high cost, a study suggested.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details